Literature DB >> 12476008

Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite doses.

Frank Dreher1, Frédéric Fouchard, Claire Patouillet, Michèle Andrian, Jean-Thierry Simonnet, Florence Benech-Kieffer.   

Abstract

The use of human skin models for performing cutaneous bioavailability studies has been little investigated. For instance, only few studies have been reported on human skin models dealing with vehicle effects on percutaneous penetration. The present study aimed at evaluating the influence on caffeine's and alpha-tocopherol's cutaneous bioavailability of cosmetic vehicles such as a water-in-oil emulsion, an oil-in-water emulsion, a liposome dispersion and a hydrogel applied at finite dose using the reconstructed human skin models EpiDerm and Episkin. The results were compared with those obtained in human skin ex vivo using similar experimental conditions. It was demonstrated that the rank order of solute permeability could be correctly predicted when the preparation was applied at a finite dose in human skin models, at least when solutes with far different physicochemical properties such as caffeine and alpha-tocopherol were used. If only slight effects of cosmetic vehicle on skin bioavailability were observed in human skin ex vivo, they were less predictable using skin models. Especially, alcohol-containing vehicles seemed to behave differently in EpiDerm as well as in Episkin than on human skin ex vivo. Stratum corneum intercellular lipid composition and organization of human skin models differ to some extent from that of human stratum corneum ex vivo, which contributes to less pronounced barrier properties, together with the increased hydration of the outermost stratum corneum layers of the models. These features, as well as still unknown factors, may explain the differences observed in vehicle effects in human skin ex vivo versus human skin models. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12476008     DOI: 10.1159/000066680

Source DB:  PubMed          Journal:  Skin Pharmacol Appl Skin Physiol        ISSN: 1422-2868


  4 in total

Review 1.  Engineered Skin Tissue Equivalents for Product Evaluation and Therapeutic Applications.

Authors:  Sana Suhail; Naseem Sardashti; Devina Jaiswal; Swetha Rudraiah; Manoj Misra; Sangamesh G Kumbar
Journal:  Biotechnol J       Date:  2019-05-17       Impact factor: 4.677

2.  Effects of growth conditions on the barrier properties of a human skin equivalent.

Authors:  Priya Batheja; Yifan Song; Philip Wertz; Bozena Michniak-Kohn
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

3.  Effect of Application Amounts on In Vitro Dermal Absorption Test Using Caffeine and Testosterone.

Authors:  Jueng-Eun Im; Hyang Yeon Kim; Jung Dae Lee; Jin-Ju Park; Kyung-Soo Kang; Kyu-Bong Kim
Journal:  Pharmaceutics       Date:  2021-04-30       Impact factor: 6.321

4.  Reconstructed Human Epidermis: An Alternative Approach for In Vitro Bioequivalence Testing of Topical Products.

Authors:  Ana Sofia Agonia; Ana Palmeira-de-Oliveira; Catarina Cardoso; Cátia Augusto; Christian Pellevoisin; Christelle Videau; Ricardo Jorge Dinis-Oliveira; Rita Palmeira-de-Oliveira
Journal:  Pharmaceutics       Date:  2022-07-26       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.